Trial intelligence / Profile preview

Suzetrigine vs Standard Analgesia for Postoperative Pain in Skin Cancer Surgery

NCT07843134Phase 4Not yet recruiting

Sponsor
University of Minnesota
Start
Apr 2027
Primary completion
Apr 2029
Countries
1
01

Overview

A Phase 4 trial of suzetrigine in acute pain, postoperative pain, sponsored by University of Minnesota. Planned start Apr 2027; status: not yet recruiting.

02

Drugs

suzetrigine
03

Conditions

acute painpostoperative pain

Beyond the preview

Go deeper on NCT07843134.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07843134.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call